 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Alzheimer disease is characterized by progressive loss of mental abilities (dementia). It is the most common type of dementia. It usually occurs after 60 years of age. The exact cause of Alzheimer disease is not known. Several factors probably play a role, including a specific allele of a gene called apolipoprotein E (apoE
SUMMARIES FOR PATIENTS
Genes and Alzheimer Disease
6 August 2002 | Volume 137 Issue 3 | Page I-18
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Apolipoprotein E 
4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease." It is in the 6 August 2002 issue of Annals of Internal Medicine (volume 137, pages 149-155). The authors are M Kivipelto, E-L Helkala, MP Laakso, T Hänninen, M Hallikainen, K Alhainen, S Iivonen, A Mannermaa, J Tuomilehto, A Nissinen, and H Soininen.
What is the problem and what is known about it so far?
There are thousands of genes in a human body cell. The genes occur on 23 pairs of chromosomes. Each gene on a chromosome has a counterpart on the matching chromosome. Genes in a matching pair may be identical or different. Different forms of the same gene are known as alleles. A single gene may have a few or several hundred different alleles. Alleles account for the inherited differences among people, such as varying eye and hair color. Alleles may also play a part in the cause and progression of diseases. 4 allele), high blood pressure, and high cholesterol level. However, how these factors relate to each other in increasing the risk for Alzheimer disease has not been clear.
Why did the researchers do this particular study?
To see whether having the apoE 4 allele increases a person's risk for Alzheimer dementia, independent of blood pressure and cholesterol level.
Who was studied?
1449 Finnish adults 65 to 79 years of age.
How was the study done?
The researchers started this study in the 1970s and 1980s. During that time, the researchers invited random samples of people living in two towns in Finland to answer several questions about their health. Participants also had their blood pressure measured and blood samples taken. During 1997 and 1998, the researchers asked 2000 of the original participants to return for another evaluation. Of these 2000 people, 1449 returned to answer several follow-up questions about their health, including questions that assessed whether they had dementia. The researchers then looked at whether apoE 4 and blood pressure and cholesterol levels measured during examinations from the initial studies were related to having dementia later in life.
What did the researchers find?
The apoE 4 allele, high cholesterol levels, and high systolic blood pressure all independently increased the risk for Alzheimer disease. The degree of risk associated with high systolic blood pressure and high cholesterol levels appeared greater than the risk associated with the apoE 4 allele.
What were the limitations of the study?
The study could look only at whether certain factors are associated with an increased risk for dementia. The study does not tell us whether treating high blood pressure and high cholesterol will reduce risk. In addition, some people who participated in the original examinations (from 1970 to 1980) died before the 1997 to 1998 reexamination period. Some of these patients may have had dementia, and factors associated with their dementia may have been different.
What are the implications of the study?
Having the apoE 4 allele, a high cholesterol level, or high systolic blood pressure increases a person's risk for dementia in later life. Although this study did not test benefits of treatment, factors that are potentially treatable (high cholesterol level and blood pressure) may be more important than "what is in the genes" (the apoE 4 allele).
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  G. Hu, R. Antikainen, P. Jousilahti, M. Kivipelto, and J. Tuomilehto Total cholesterol and the risk of Parkinson disease Neurology, May 20, 2008; 70(21): 1972 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Anstey, D. M. Lipnicki, and L.-F. Low Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis Am J Geriatr Psychiatry, May 1, 2008; 16(5): 343 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J Whalley, I. J Deary, J. M Starr, K. W Wahle, K. A Rance, V. J Bourne, and H. C Fox n-3 Fatty acid erythrocyte membrane content, APOE {varepsilon}4, and cognitive variation: an observational follow-up study in late adulthood Am. J. Clinical Nutrition, February 1, 2008; 87(2): 449 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Mielke, P. B. Rosenberg, J. Tschanz, L. Cook, C. Corcoran, K. M. Hayden, M. Norton, P. V. Rabins, R. C. Green, K. A. Welsh-Bohmer, et al. Vascular factors predict rate of progression in Alzheimer disease Neurology, November 6, 2007; 69(19): 1850 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Furie and E. E. Smith Metabolic syndrome: A target for preventing leukoaraiosis and age-related dementia? Neurology, September 4, 2007; 69(10): 951 - 952. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Scarmeas Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I? Am. J. Epidemiol., May 1, 2007; 165(9): 993 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guizzetti and L. Costa Cholesterol homeostasis in the developing brain: a possible new target for ethanol Human and Experimental Toxicology, April 1, 2007; 26(4): 355 - 360. [Abstract] [PDF]
|
|
|
|
|
|
A. Solomon, I. Kareholt, T. Ngandu, B. Winblad, A. Nissinen, J. Tuomilehto, H. Soininen, and M. Kivipelto Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study Neurology, March 6, 2007; 68(10): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stewart, L. R. White, Q.-L. Xue, and L. J. Launer Twenty-six-Year Change in Total Cholesterol Levels and Incident Dementia: The Honolulu-Asia Aging Study Arch Neurol, January 1, 2007; 64(1): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Borroni, M. Grassi, C. Costanzi, S. Archetti, L. Caimi, and A. Padovani APOE Genotype and Cholesterol Levels in Lewy Body Dementia and Alzheimer Disease: Investigating Genotype-Phenotype Effect on Disease Risk Am J Geriatr Psychiatry, December 1, 2006; 14(12): 1022 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Burns and J. O'Brien Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol, November 1, 2006; 20(6): 732 - 755. [Abstract] [PDF]
|
|
|
|
|
|
F. Bursi, W. A. Rocca, J. M. Killian, S. A. Weston, D. S. Knopman, S. J. Jacobsen, and V. L. Roger Heart Disease and Dementia: A Population-based Study Am. J. Epidemiol., January 15, 2006; 163(2): 135 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Mitchell, J. A. Vita, M. G. Larson, H. Parise, M. J. Keyes, E. Warner, R. S. Vasan, D. Levy, and E. J. Benjamin Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic Stiffness: The Framingham Heart Study Circulation, December 13, 2005; 112(24): 3722 - 3728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W M van der Flier and P Scheltens Epidemiology and risk factors of dementia J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(suppl_5): v2 - v7. [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Cole, A. Grudzien, I. O. Manhart, B. L. Kelly, H. Oakley, and R. Vassar Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, {beta}-Secretase-cleaved Fragments, and Amyloid {beta}-Peptide via an Isoprenoid-dependent Mechanism J. Biol. Chem., May 13, 2005; 280(19): 18755 - 18770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dufouil, F. Richard, N. Fievet, J. F. Dartigues, K. Ritchie, C. Tzourio, P. Amouyel, and A. Alperovitch APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study Neurology, May 10, 2005; 64(9): 1531 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Lane and M. R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res., May 1, 2005; 46(5): 949 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Purandare, C. Ballard, and A. Burns Preventing dementia Advan. Psychiatr. Treat., May 1, 2005; 11(3): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tuomilehto Primary Prevention of Type 2 Diabetes: Lifestyle Intervention Works and Saves Money, but What Should Be Done with Smokers? Ann Intern Med, March 1, 2005; 142(5): 381 - 383. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Koldamova, I. M. Lefterov, M. Staufenbiel, D. Wolfe, S. Huang, J. C. Glorioso, M. Walter, M. G. Roth, and J. S. Lazo The Liver X Receptor Ligand T0901317 Decreases Amyloid {beta} Production in Vitro and in a Mouse Model of Alzheimer's Disease J. Biol. Chem., February 11, 2005; 280(6): 4079 - 4088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Blair, A. R. Folsom, D. S. Knopman, M. S. Bray, T. H. Mosley, E. Boerwinkle, and for the Atherosclerosis Risk in Communities Study APOE genotype and cognitive decline in a middle-aged cohort Neurology, January 25, 2005; 64(2): 268 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hajjar, H. Catoe, S. Sixta, R. Boland, D. Johnson, V. Hirth, D. Wieland, and P. Eleazer Cross-Sectional and Longitudinal Association Between Antihypertensive Medications and Cognitive Impairment in an Elderly Population J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2005; 60(1): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Elkins, E. S. O'Meara, W. T. Longstreth Jr., M. C. Carlson, T. A. Manolio, and S. C. Johnston Stroke risk factors and loss of high cognitive function Neurology, September 14, 2004; 63(5): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhang, A. Matsunaga, K. Saku, S. Nakano, and T. Yamada Associations Among Plasma Lipoprotein Subfractions as Characterized by Analytical Capillary Isotachophoresis, Apolipoprotein E Phenotype, Alzheimer Disease, and Mild Cognitive Impairment Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): e144 - e144. [Full Text] [PDF]
|
|
|
|
|
|
L. E. Hebert, P. A. Scherr, D. A. Bennett, J. L. Bienias, R. S. Wilson, M. C. Morris, and D. A. Evans Blood pressure and late-life cognitive function change: A biracial longitudinal population study Neurology, June 8, 2004; 62(11): 2021 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Qiu, M Kivipelto, H Aguero-Torres, B Winblad, and L Fratiglioni Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 828 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Morris, D. A. Evans, J. L. Bienias, C. C. Tangney, and R. S. Wilson Dietary fat intake and 6-year cognitive change in an older biracial community population Neurology, May 11, 2004; 62(9): 1573 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Elkins, V. C. Douglas, and S. C. Johnston Alzheimer disease risk and genetic variation in ACE: A meta-analysis Neurology, February 10, 2004; 62(3): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J Miller and R. Chacko The Role of Cholesterol and Statins in Alzheimer's Disease Ann. Pharmacother., January 1, 2004; 38(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D. C. Luehrs, J. D. Seward, L. I. Sue, and T. G. Beach Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer's Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2055 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Merikangas and N. Risch Will the Genomics Revolution Revolutionize Psychiatry? Am J Psychiatry, April 1, 2003; 160(4): 625 - 635. [Full Text] [PDF]
|
|
|
|
 |
|
 Contributions of Cholesterol, BP, and Genetics in Alzheimer's Disease Journal Watch Cardiology, November 1, 2002; 2002(1101): 6 - 6. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
